Definition of follicular stromal cell subset interactions with B cells
滤泡基质细胞亚群与 B 细胞相互作用的定义
基本信息
- 批准号:8492703
- 负责人:
- 金额:$ 8.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-01-01 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:Activated LymphocyteAdjuvantAntigensArchitectureAreaAssesB-LymphocytesBehaviorBloodBone MarrowCell CommunicationCellsCellular MorphologyChimera organismCollectionComplexDendritesEndothelial CellsEnvironmentEventFingerprintFollicular Dendritic CellsHistologyImmune responseImmunizationIn SituLaser Scanning MicroscopyLymphLymph Node Subcapsular SinusLymphocyteLymphocyte antigenLymphoid TissueMediatingMorphologyMovementMusNeighborhoodsPericytesPositioning AttributeRelative (related person)Research InfrastructureReticular CellRoleSignal TransductionStromal CellsStructureSynapsesT-LymphocyteTestingTimeTissuesVaccinesameboid movementbasecell motilitycell typechemokinechemokine receptorintravital imagingintravital microscopynotch proteinpathogenpublic health relevancereceptor expressionreconstructionresearch studyresponsetwo-photon
项目摘要
DESCRIPTION (provided by applicant): The initiation of immune responses within lymphoid tissue involves a carefully orchestrated movement of activated lymphocytes within an elaborate network of stationary stromal cells. Lymphoid tissue architecture is comprised of distinguishable microanatomic "neighborhoods" that are based on a complex arrangement of stromal cells. Due to the secretion of distinctive combinations of chemokines by stromal cell subsets, the chemokine fingerprint within B cell follicles is distinguishable from its neighboring T cell zone. Through shifts in chemokine receptor expression after activation, antigen engaged B and T cells reposition themselves to congregate within new niches, promoting their cognate encounters and enabling key steps in the differentiation of critical effectors. Although on a macro scale, the uniform distribution of na¿ve B cells throughout the follicle might suggest a similar uniformity in
the stationary structural underpinnings, there are instead many stromal cell subsets positioned within follicles. In addition to the well characterized follicular dendritic cell (FDC), B cell folicles also harbor lymph and blood endothelial cells, the later covered by pericytes. Fibroblastic reticular cells rim the inside edge of the border of the follicle closest to the T cell zone, wheres the subcapsular sinus lining is a collection of yet more cell types including a marginal reticular cell with descending dendrites. Despite the critical role of stromal cells in defining the landmark for lymphocyte orientation during initial activation events, many fundamental aspects of B cell interactions with follicular stroma are unknown. Here we propose to examine the interactions between B cells and the stromal cell subsets that make up the follicular infrastructure. Aim 1: Define the stromal cell framework of B cell follicles. Using intravital microscopy of fluorescent bone marrow chimeras, the relative positioning of blood and lymph vessels vis-¿-vis FDCs and other intra-follicular stromal cells will be defined. We will assess the consistency of their juxtapositions, spacing and associated cell types before and after immunization. Aim 2: Define the propensity of na¿ve and activated B cells to interact with stromal cell subsets via intravital microscopy. The morphodynamics and mode of propulsion between B cells in contact with stroma will be compared to those within regions that lack stroma, and the impact of blood or lymph-borne antigen/adjuvants on this behavior determined. Motility parameters of na¿ve and activated B cells within stromal gaps will be quantified to test the hypothesis that such movement is transient and a directed shift from one stromal contact to another. Aim 3: Examine B cells in situ for intracellular indicators of potential signaling events during contacts with strmal cell subsets. B cells with synaptic morphology adjacent to stromal cells will be examined by histology for intracellular indicators of Notch, BMP and BCR mediated signaling coincident with stromal cell subset contacts. To test the hypothesis that such contacts support BCR derived tonic signaling, we will perform intravital imaging of B cells transfected with a NFAT-eGFP retroviral construct within LNs of fluorescent BM chimeras.
描述(由申请人提供):淋巴组织内免疫应答的启动涉及激活淋巴细胞在固定基质细胞的复杂网络中精心安排的运动。淋巴组织结构由基于基质细胞复杂排列的可区分的微观解剖“邻域”组成。由于基质细胞亚群分泌不同的趋化因子组合,B细胞滤泡内的趋化因子指纹与邻近的T细胞区是可区分的。通过趋化因子受体激活后表达的变化,抗原参与的B细胞和T细胞重新定位自己,聚集在新的生态位中,促进它们的同源相遇,并使关键效应物分化的关键步骤成为可能。尽管在宏观尺度上,na - ve B细胞在整个卵泡中的均匀分布可能暗示了类似的均匀性
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANN M HABERMAN其他文献
ANN M HABERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANN M HABERMAN', 18)}}的其他基金
Regulation of germinal center B cell fate choice by Hedgehog signaling
Hedgehog 信号传导调控生发中心 B 细胞命运选择
- 批准号:
10570972 - 财政年份:2022
- 资助金额:
$ 8.31万 - 项目类别:
Regulation of germinal center B cell fate choice by Hedgehog signaling
Hedgehog 信号传导调控生发中心 B 细胞命运选择
- 批准号:
10452342 - 财政年份:2022
- 资助金额:
$ 8.31万 - 项目类别:
Definition of follicular stromal cell subset interactions with B cells
滤泡基质细胞亚群与 B 细胞相互作用的定义
- 批准号:
8600651 - 财政年份:2013
- 资助金额:
$ 8.31万 - 项目类别:
Analysis of B cell transcriptome shifts prior to lineage divergence in vivo
体内谱系分歧之前 B 细胞转录组变化的分析
- 批准号:
8356988 - 财政年份:2012
- 资助金额:
$ 8.31万 - 项目类别:
Analysis of B cell transcriptome shifts prior to lineage divergence in vivo
体内谱系分歧之前 B 细胞转录组变化的分析
- 批准号:
8494565 - 财政年份:2012
- 资助金额:
$ 8.31万 - 项目类别:
In vivo imaging of T and B cell interactions in germinal center initiation
生发中心启动过程中 T 细胞和 B 细胞相互作用的体内成像
- 批准号:
7888316 - 财政年份:2009
- 资助金额:
$ 8.31万 - 项目类别:
In vivo imaging of T and B cell interactions in germinal center initiation
生发中心启动过程中 T 细胞和 B 细胞相互作用的体内成像
- 批准号:
8082659 - 财政年份:2009
- 资助金额:
$ 8.31万 - 项目类别:
In vivo imaging of T and B cell interactions in germinal center initiation
生发中心启动过程中 T 细胞和 B 细胞相互作用的体内成像
- 批准号:
8286885 - 财政年份:2009
- 资助金额:
$ 8.31万 - 项目类别:
In vivo imaging of T and B cell interactions in germinal center initiation
生发中心启动过程中 T 细胞和 B 细胞相互作用的体内成像
- 批准号:
7728098 - 财政年份:2009
- 资助金额:
$ 8.31万 - 项目类别:
相似海外基金
Identifying the Most Effective Adjuvant(s) for Leading Group A Streptococcal Vaccine Antigens in Preclinical Mouse and Nonhuman Primate Models
在临床前小鼠和非人灵长类动物模型中确定 A 组链球菌疫苗抗原最有效的佐剂
- 批准号:
10577066 - 财政年份:2023
- 资助金额:
$ 8.31万 - 项目类别:
Lymph node-targeted codelivery of albumin-binding peptide antigens and di-adjuvant for melanoma combination immunotherapy
用于黑色素瘤联合免疫治疗的白蛋白结合肽抗原和双佐剂的淋巴结靶向共递送
- 批准号:
10522591 - 财政年份:2022
- 资助金额:
$ 8.31万 - 项目类别:
Lymph Node-Targeted Codelivery of Albumin-Binding Peptide Antigens and Di-Adjuvant for Melanoma Combination Immunotherapy
用于黑色素瘤联合免疫治疗的白蛋白结合肽抗原和双佐剂的淋巴结靶向共递送
- 批准号:
10884052 - 财政年份:2022
- 资助金额:
$ 8.31万 - 项目类别:
Establishment of postoperative adjuvant immunotherapy using peptide pool of tumor antigens in advanced esophageal cancer
晚期食管癌肿瘤抗原肽库术后辅助免疫治疗的建立
- 批准号:
15K10100 - 财政年份:2015
- 资助金额:
$ 8.31万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of cancer vaccine using adjuvant function encrypted artificial antigens
使用佐剂功能加密人工抗原开发癌症疫苗
- 批准号:
26430172 - 财政年份:2014
- 资助金额:
$ 8.31万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Alpha-galactosycleramide as a mucosal adjuvant for HIV antigens
α-半乳糖酰胺作为 HIV 抗原的粘膜佐剂
- 批准号:
7849955 - 财政年份:2009
- 资助金额:
$ 8.31万 - 项目类别:
Alpha-galactosycleramide as a mucosal adjuvant for HIV antigens
α-半乳糖酰胺作为 HIV 抗原的粘膜佐剂
- 批准号:
7627172 - 财政年份:2009
- 资助金额:
$ 8.31万 - 项目类别:
RECOMBINANT MIF AS AN ADJUVANT FOR HIV ANTIGENS
重组 MIF 作为 HIV 抗原的佐剂
- 批准号:
2068228 - 财政年份:1992
- 资助金额:
$ 8.31万 - 项目类别:
RECOMBINANT MIF AS AN ADJUVANT FOR HIV ANTIGENS
重组 MIF 作为 HIV 抗原的佐剂
- 批准号:
3548034 - 财政年份:1992
- 资助金额:
$ 8.31万 - 项目类别:
RECOMBINANT MIF AS AN ADJUVANT FOR HIV ANTIGENS
重组 MIF 作为 HIV 抗原的佐剂
- 批准号:
3548033 - 财政年份:1992
- 资助金额:
$ 8.31万 - 项目类别:














{{item.name}}会员




